News + Resources

Keep up with the latest

Featured

This Scientist Is Building Custom Gene-Editing Tools

This Scientist Is Building Custom Gene-Editing Tools

Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024

November 25, 2024

Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024

November 25, 2024

CRISPR 2.0, the Next Generation

June 21, 2024

Aspen Ideas: Health

CRISPR 2.0, the Next Generation

June 21, 2024

The Age of CRISPR: Engineering the Future of Genetic Medicine

February 23, 2024

TEDxBerkeley

The Age of CRISPR: Engineering the Future of Genetic Medicine

February 23, 2024

Scribe Therapeutics Picks Cholesterol-Lowering As First In Vivo Gene Target

February 7, 2024

Scrip

Scribe Therapeutics Picks Cholesterol-Lowering As First In Vivo Gene Target

February 7, 2024

All Stories

All
News
Press Releases
News

CRISPR technologies fuelling haematological innovations

April 12, 2024

European Pharmaceutical Review

Read Now
News

CRISPR drug licensing deals secure $21bn in top three therapy areas over five years

March 28, 2024

Pharmaceutical Technology

Read Now
News

Benjamin Oakes and the Promise of CRISPR

March 5, 2024

Sounds of Science

Read Now
News

The Age of CRISPR: Engineering the Future of Genetic Medicine

February 23, 2024

TEDxBerkeley

Read Now
News

CRISPR by Design with Benjamin Oakes

February 20, 2024

Andreessen Horowitz

Read Now
News

CRISPR Partnerships Propel Precision Medicine

February 20, 2024

CRISPR Medicine News

Read Now
Press release

Scribe Therapeutics to Participate in Upcoming Conferences

September 12, 2024

Read Now
Press release

Scribe Therapeutics Presents Data Demonstrating Highly Potent Gene Editing In Vivo, Including Saturated Editing of Hepatocytes in NHPs, by an Engineered XE Genome Editor; Showcases Novel Epigenetic Editing Capabilities at 2024 ASGCT Annual Meeting

May 10, 2024

Read Now
Press release

Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

April 22, 2024

Read Now
Press release

Scribe Therapeutics to Participate in the Leerink Partners Global Biopharma Conference

March 6, 2024

Read Now
Press release

Scribe Therapeutics Expands In Vivo Collaboration with Sanofi to Second Target

January 3, 2024

Read Now
Press release

Scribe Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 2, 2024

Read Now

Publications and presentations